De-pei Li

Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics.

Zhenqiang He, Yinsheng Chen, Chengcheng Guo, 2022, Journal of neurosurgery.

The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis

Xiaobing Jiang, Yu-feng Zou, Depei Li, 2021, BMC Endocrine Disorders.

Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas

Yinsheng Chen, K. Sai, Xiaobing Jiang, 2019, Journal of Neuro-Oncology.

Real-world management and survival outcomes of patients with newly diagnosed gliomas from a single institution in China: A retrospective cohort study

Yinsheng Chen, Chengcheng Guo, K. Sai, 2019, Glioma.

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.

J. Zeng, Yinsheng Chen, M. Deng, 2023, JAMA network open.

Disruption of β-catenin-mediated negative feedback reinforces cAMP-induced neuronal differentiation in glioma stem cells

Xin-cheng Liu, K. Sai, Y. Mou, 2022, Cell Death & Disease.

Trend and socioeconomic disparities in survival outcome of metastatic melanoma after approval of immune checkpoint inhibitors: a population-based study.

Zhenqiang He, Chengcheng Guo, Xiaobing Jiang, 2020, American journal of translational research.

CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas

J. Zeng, Zhenqiang He, S. Zhong, 2021, Frontiers in Cell and Developmental Biology.

Incidence, trend and risk factors associated with suicide among patients with malignant intracranial tumors: a surveillance, epidemiology, and end results analysis

K. Sai, Xiaobing Jiang, Y. Mou, 2022, International Journal of Clinical Oncology.